Toumai® Endoscopic Robot Completes First Domestic Robot-assisted Single-port Procedure

Hangzhou, China, the Toumai® Endoscopic Surgery Robotic System (Toumai® Endoscopic Robot), a proprietary product of Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot), a Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) subsidiary, has now completed the first robot-assisted single-port partial nephrectomy at Zhejiang Provincial People’s Hospital.

The patient, a 66-year-old female, was found to have left renal masses on routine ultrasound examination 11 days before the operation. The surgical team led by Prof. Zhang and Director Mao developed a detailed preoperative plan for the patient’s condition and decided to perform a robotic-assisted single-port partial nephrectomy using the Toumai® Endoscopic Robot. The operation is also the first domestic single-port procedure assisted by a made-in-China endoscopic robot.

“We have performed multiple robot-assisted partial nephrectomy surgeries using the Toumai® Endoscopic Robot.” Prof. Zhang commented after the surgery, “The success of the first domestic robot-assisted single-port partial nephrectomy in China has given us even more confidence in the Toumai® Endoscopic Robot. With the support of stable and sharp 3D surgical view, and the flexible and sophisticated instruments provided by the Toumai® Endoscopic Robot, surgeons could perform a series of high-precision and complex operations in a limited space. Thus helping reduce patients’ surgical trauma, alleviate postoperative pain and promote recovery while ensuring the safety and effectiveness of treatment.”

Dr. Chao He, President of MicroPort® MedBot, said, “The success of the first robot-assisted single-port partial nephrectomy in China marks another milestone in the clinical application of Toumai® Endoscopic Robot. With this, Toumai® Endoscopic Robot has become the second endoscopic robot in the world to be used in a single-port procedure, right after the da Vinci Surgical System. With the recognition of clinical experts, we are confident that we will continue to work together with those experts to provide inclusive and intelligent surgical solutions that can save patients’ lives or reshape their quality of life.”

Compared with conventional laparoscopic single-port surgery, the robot-assisted surgery enables the ability to overcome the current constraints, limiting conventional surgical instruments and reverse manipulations that are common in the traditional single-port operations. Furthermore, the accuracy of medical robots is more prominent when they are used in surgeries that require a high level of precision. Surgical results are comparable to those of multiport procedures, while it provides additional benefits such as minimal invasiveness, safety, aesthetics, as well as less postoperative pain and quicker recovery.